Folgen
Harika Nagandla
Harika Nagandla
Houston Methodist
Bestätigte E-Mail-Adresse bei houstonmethodist.org
Titel
Zitiert von
Zitiert von
Jahr
Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1
H Nagandla, S Lopez, W Yu, TL Rasmussen, HO Tucker, RJ Schwartz, ...
Developmental biology 410 (1), 86-97, 2016
372016
Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray
MD Stewart, S Lopez, H Nagandla, B Soibam, A Benham, J Nguyen, ...
Disease models & mechanisms 9 (3), 347-359, 2016
352016
Cardiomyocyte-specific conditional knockout of the histone chaperone HIRA in mice results in hypertrophy, sarcolemmal damage and focal replacement fibrosis
N Valenzuela, Q Fan, F Fa'ak, B Soibam, H Nagandla, Y Liu, RJ Schwartz, ...
Disease Models & Mechanisms 9 (3), 335-345, 2016
242016
Isoform-specific activities of androgen receptor and its splice variants in prostate cancer cells
H Nagandla, MJ Robertson, V Putluri, N Putluri, C Coarfa, NL Weigel
Endocrinology 162 (3), bqaa227, 2021
102021
Anti-metastatic effects of estrogen receptor β in inflammatory breast cancer
H Nagandla, S Tastsoglou, KC Cap, A Phillips, W Qian, J Zhou, J Chang, ...
Cancer Research 84 (6_Supplement), 6270-6270, 2024
2024
Novel LIPA targeted therapy for treating inflammatory breast cancer
Z Fuentes, R Gopalam, BA Romo, KM Nassar, X Yang, B Ebrahimi, ...
Cancer Research 84 (6_Supplement), 2100-2100, 2024
2024
Crosstalk of estrogen receptor Β with tumor microenvironment signaling explains tumor suppressor actions in TNBC
KDA Zambo, H Nagandla, KC Cap, A Phillips, F Nikolos, W Qian, J Zhou, ...
Cancer Research 84 (6_Supplement), 5550-5550, 2024
2024
Abstract B013: Understanding the anti-metastatic activity of estrogen receptor β in inflammatory breast cancer
I Karagounis, S Tastsoglou, H Nagandla, N Ueno, A Maity, ...
Cancer Research 84 (3_Supplement_1), B013-B013, 2024
2024
ERβ as a mediator of estrogen signaling in inflammatory breast cancer
H Nagandla, C Thomas
Oncotarget 14, 576, 2023
2023
SUN-LB136 A Comparison of Androgen Receptor Splice Variant, AR-V7, and Glucocorticoid Receptor Activity in Prostate Cancer
AK Dash, B Paul, MJ Robertson, H Nagandla, KI Rajapakshe, C Coarfa, ...
Journal of the Endocrine Society 4 (Supplement_1), SUN-LB136, 2020
2020
SUN-001 Analysis of Isoform Specific Differential Splicing Effects in Prostate Cancer
M Rana, J Dong, B Paul, H Nagandla, M Robertson, C Coarfa, N Weigel
Journal of the Endocrine Society 3 (Supplement_1), SUN-001, 2019
2019
Quantification of Embryonic Myofiber Development by Immunofluorescence
H Nagandla, MD Stewart
Skeletal Muscle Development, 167-176, 2017
2017
A Requirement for the Lysine Methyl Transferase SMYD1 in Myoblast Differentiation
H Nagandla
2015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–13